TCL Archive Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects December 30, 2011
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online February 5, 1999
TCL Archive 32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening September 21, 1990
